Our Pricing

Published on: June 03, 2026

When you buy Wegovy FlexTouch pen UK online from Cured Pharmacy, you receive genuine UK-licensed semaglutide injections from £79.00, with transparent upfront pricing and a free clinical assessment completed in under three minutes. Our GPhC-registered service (9012511) connects you with UK prescribers who evaluate your suitability for this once-weekly weight loss treatment, ensuring safe and compliant access to one of the most effective obesity medications available.

How Wegovy FlexTouch Pen Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics a natural gut hormone that regulates appetite and food intake, helping you feel fuller for longer periods after meals.

The FlexTouch pen delivery system provides a pre-filled, single-use injection device designed for subcutaneous administration once weekly. Each pen contains a fixed dose of semaglutide in a ready-to-use format, eliminating the need for manual dose drawing or vial handling. Clinical trials demonstrated that patients using Wegovy achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1].

Semaglutide works by slowing gastric emptying, reducing appetite signals in the brain, and improving glycaemic control. These combined mechanisms support sustained weight loss when used alongside a reduced-calorie diet and increased physical activity, as recommended by NICE guidelines for obesity management [2].

Wegovy Dosing Schedule and FlexTouch Pen Strengths

Wegovy treatment follows a structured dose escalation schedule designed to minimise gastrointestinal side effects while optimising therapeutic response. Your UK prescriber will initiate treatment at 0.25 mg once weekly for four weeks, then increase progressively through 0.5 mg, 1 mg, and 1.7 mg doses before reaching the maintenance dose of 2.4 mg weekly [3].

Each FlexTouch pen is colour-coded and labelled with its specific strength, ensuring accurate dose administration throughout your treatment journey. The gradual titration protocol allows your body to adjust to semaglutide's effects, reducing the likelihood of nausea and vomiting that can occur with rapid dose increases.

What Happens If You Miss a Dose?

If you miss a Wegovy injection and fewer than five days have passed since your scheduled dose, administer it as soon as you remember. If more than five days have elapsed, skip the missed dose and resume your regular weekly schedule. Never double up on doses to compensate for a missed injection, as this increases the risk of adverse gastrointestinal effects [3].

Clinical Evidence: STEP Trial Results for Wegovy

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme provides robust evidence for Wegovy's efficacy in weight management. In the pivotal STEP 1 trial involving 1,961 adults with obesity, participants receiving semaglutide 2.4 mg achieved a mean body weight reduction of 14.9% compared to baseline, versus 2.4% in the placebo group over 68 weeks [1].

Notably, 86.4% of participants on Wegovy achieved at least 5% weight loss, 69.1% achieved at least 10% weight loss, and 50.5% achieved at least 15% weight loss—outcomes that significantly exceeded placebo responses across all thresholds [1]. These results represent some of the most substantial weight reductions observed with pharmacotherapy in obesity treatment.

The STEP 5 trial extended follow-up to 104 weeks, demonstrating sustained weight loss maintenance with continued semaglutide treatment. Participants maintained an average 15.2% reduction from baseline weight, confirming that Wegovy supports long-term weight management when used as part of a comprehensive lifestyle intervention programme [4].

Cardiovascular and Metabolic Benefits

Beyond weight reduction, STEP trial participants experienced improvements in cardiometabolic risk factors including reductions in waist circumference, systolic blood pressure, HbA1c levels in those with prediabetes, and improvements in lipid profiles [1]. These secondary benefits contribute to overall health improvements associated with clinically significant weight loss.

Buy Wegovy FlexTouch Pen UK: Price and Value Comparison

At Cured Pharmacy, Wegovy is available from £79.00 per pen, representing competitive UK pricing with transparent costs displayed before you begin your clinical consultation. This upfront pricing approach ensures you understand the financial commitment before engaging with our prescribing service, eliminating surprise costs that can occur with some online pharmacy platforms.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing operations, ensuring every Wegovy pen supplied meets UK licensing standards and originates from legitimate pharmaceutical supply chains. We guarantee 100% genuine UK-licensed medicines, protecting you from the risks associated with counterfeit or grey-market semaglutide products that have proliferated online.

The total cost of Wegovy treatment varies based on your prescribed dose and treatment duration. During the initial titration phase, you'll progress through lower-strength pens before reaching the maintenance dose, with your prescriber determining the appropriate supply schedule based on your clinical response and tolerability.

Common Side Effects and How to Manage Them

Gastrointestinal side effects represent the most frequently reported adverse reactions with Wegovy, affecting approximately 44% of participants in clinical trials [1]. Nausea, diarrhoea, vomiting, constipation, and abdominal pain typically emerge during dose escalation and often diminish as treatment continues. The gradual titration schedule specifically aims to minimise these effects.

To reduce gastrointestinal discomfort, eat smaller, more frequent meals rather than large portions, avoid high-fat and spicy foods, stay well-hydrated, and allow adequate time between your last meal and bedtime. If nausea persists or becomes severe, contact your prescriber—they may recommend temporarily maintaining your current dose before attempting further increases.

Serious but rare side effects include pancreatitis, gallbladder disease, hypoglycaemia (particularly in patients taking other glucose-lowering medications), and changes in vision. Wegovy carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3]. Your prescriber will review your personal and family medical history to ensure Wegovy is appropriate for you.

When to Seek Medical Attention

Contact your healthcare provider immediately if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis, symptoms of gallstones, or allergic reactions including rash, itching, or difficulty breathing. These symptoms require prompt medical evaluation to rule out serious complications.

Who Can Buy Wegovy FlexTouch Pen UK Online?

Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or greater, or a BMI of 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea [3]. Your UK prescriber will calculate your BMI and review your medical history during the online consultation to determine eligibility.

Wegovy is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, those with a history of severe hypersensitivity reactions to semaglutide, and during pregnancy and breastfeeding [3]. You must disclose all current medications, as Wegovy can interact with insulin and other diabetes medications, potentially requiring dose adjustments.

The online consultation at Cured Pharmacy takes under three minutes and covers your weight history, previous weight loss attempts, current medications, relevant medical conditions, and treatment goals. This clinical assessment ensures Wegovy is both safe and appropriate for your individual circumstances, with prescribing decisions made by qualified UK healthcare professionals registered with the General Pharmaceutical Council.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Novo Nordisk Limited. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., Wharton, S., & STEP 5 Study Group. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and should only be used under medical supervision as part of a comprehensive weight management programme including diet and exercise.